IP Library Granted Patent US 6,841,360
Granted Patent B2
US 6,841,360 · App. 10/608,504 · Granted Jan 11, 2005

Nucleotide sequences coding for the export of branched-chain amino acids, process for the isolation thereof and use thereof

Assignees: Degussa-Huls Aktiengesellschaft; Forschungszentrum Julich GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,841,360
App. No.
10/608,504
Granted
Jan 11, 2005
Kind
B2
Abstract

This invention relates to isolated polynucleotides containing at least one of the polynucleotide sequences selected from the group a) polynucleotide which is at least 70% identical to a polynucleotide which codes for a polypeptide containing at least one amino acid sequence of SEQ ID no. 3 or 5, b) polynucleotide which codes for a polypeptide which contains an amino acid sequence which is at least 70% identical to the amino acid sequence of SEQ ID no. 3 or 5, c) polynucleotide which is complementary to the polynucleotides of a), b) or c), and d) polynucleotide containing at least 15 successive bases of the polynucleotide sequences of a), b) or c). wherein the polypeptides exhibit the biological activity of the enzymes for which the brnE or bernF (sic)gene codes and a process for the fermentative production of branched-chain L-amino acids with amplification of the stated genes.

Claims (22)

1. A process for producing a branched chain L-amino acid, comprising:

a) cultivating a bacterium in a culture medium under conditions effective for production of said branched chain L-amino acid, wherein said bacterium has been engineered to overexpress brnE (SEQ ID NO:5) or brnF (SEQ ID NO:3); and

b) isolating said branched chain L-amino acid from the cultivated bacterium or culture medium of step a).

2. The process of claim 1 , wherein said bacterium is of the genus Corynebacterium.

3. The process of claim 2 , wherein said bacterium is of the species Corynebacterium glutamicum.

4. The process of any one of claims 1 - 3 , wherein said branched chain in L-amino acid is selected from the group consisting of: L-leucine; L-isoleucine; and L-valine.

5. A process for producing a branched chain L-amino acid, comprising:

a) transforming a bacterial host cell with a recombinant vector comprising a nucleic acid insert encoding a protein consisting essentially of the amino acid sequence of SEQ ID NO:3; the amino acid sequence of SEQ ID NO:5; or both;

b) cultivating the transformed bacterial host cell of step a) in a culture medium under conditions effective for the production of said branched chain L-amino acid; and

c) isolating said branched chain L-amino acid from the cultivated bacterial host cell or culture medium of step b).

6. The process of claim 5 , wherein said nucleic acid insert consists essentially of a nucleic acid sequence selected from the group consisting of: SEQ ID NO:1; nucleotides 101-1176 of SEQ ID NO:1; SEQ ID NO:2; and SEQ ID NO:4.

7. The process of claim 5 , wherein said nucleic acid insert consists o a nucleic acid sequence selected from the group consisting of: SEQ ID NO:1; nude tides 101-1176 of SEQ ID NO:1; SEQ ID NO:2; and SEQ ID NO:4.

8. The process of claim wherein said nucleic acid insert consists essentially of nucleotides 101-853 of SEQ ID NO:6or nucleotides 853-1176 of SEQ ID NO:6.

9. The process of claim 8 , wherein said nucleic acid insert consists of nucleotides 101-853 of SEQ ID NO:6 or nucleotides 853-1176 of SEQ ID:6.

10. The process of claim 5 , wherein said nucleic acid insert comprises:

a) nucleotides encoding a first polypeptide, said first polypeptide consisting essentially of the amino acid sequence of SEQ ID NO:3; and

b) nucleotides encoding a second distinct polypeptide, said second distinct polypeptide consisting essentially of the amino acid sequence of SEQ ID NO:5.

11. The process of claim 5 , wherein said nucleic acid insert consists essentially of the nucleotide sequence of SEQ ID NO:2 and the nucleotide sequence of SEQ ID NO:4.

12. The process of claim 11 , wherein said nucleic acid insert consists of the nucleotide sequence of SEQ ID NO:2 and the nucleotide sequence of SEQ D NO:4.

13. The process of any one of claims 5 - 12 , wherein said bacterium is of the genus Corynebacterium.

14. The process of claim 13 , wherein said bacterium is of the species Corynebacterium glutamicum.

15. The process of any one of claims 5 - 12 , wherein said branched chain L-amino acid is selected from the group consisting of: L-leucine; L-isoleucine; and -valine.

Assignments (5)
CHANGE OF NAME Recorded Feb 22, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 052044/0523 →
CHANGE OF NAME Recorded Feb 23, 2010
From: DEGUSSA GMBH
To: EVONIK DEGUSSA GMBH
Reel/Frame 024006/0127 →
CHANGE ADDRESS Recorded Feb 22, 2010
From: EVONIK DEGUSSA GMBH
To: EVONIK DEGUSSA GMBH
Reel/Frame 023985/0296 →
CHANGE OF ENTITY Recorded Feb 22, 2010
From: DEGUSSA AG
To: DEGUSSA GMBH
Reel/Frame 023998/0937 →
MERGER Recorded Mar 29, 2006
From: AKTIENGESELLSCHAFT, DEGUSSA-HULS
To: DEGUSSA AG
Reel/Frame 017400/0338 →
Priority Claims (1)
DE 199 51 708 · Oct 27, 1999 · national
Continuity (2)
Division 0947180300 · Dec 23, 1999
Related Publication 20040014123A1 · Jan 22, 2004